These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 31315304)

  • 21. Genetic polymorphisms associated with sulphadoxine-pyrimethamine drug resistance among Plasmodium falciparum field isolates in malaria endemic areas of Assam.
    Sharma J; Dutta P; Khan SA; Soni M; Dey D; Mahanta J
    J Postgrad Med; 2015; 61(1):9-14. PubMed ID: 25511211
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low-grade sulfadoxine-pyrimethamine resistance in Plasmodium falciparum parasites from Lubango, Angola.
    Kaingona-Daniel EP; Gomes LR; Gama BE; Almeida-de-Oliveira NK; Fortes F; Ménard D; Daniel-Ribeiro CT; Ferreira-da-Cruz Mde F
    Malar J; 2016 Jun; 15():309. PubMed ID: 27267365
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Frequencies distribution of dihydrofolate reductase and dihydropteroate synthetase mutant alleles associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum population from Hadhramout Governorate, Yemen.
    Bamaga OA; Mahdy MA; Lim YA
    Malar J; 2015 Dec; 14():516. PubMed ID: 26693691
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Investigating selected host and parasite factors potentially impacting upon seasonal malaria chemoprevention in Bama, Burkina Faso.
    Somé FA; Bazié T; Ehrlich HY; Goodwin J; Lehane A; Neya C; Zachari K; Wade M; Ouattara JM; Foy BD; Dabiré RK; Parikh S; Ouédraogo JB
    Malar J; 2020 Jul; 19(1):238. PubMed ID: 32631416
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High prevalence of pfdhfr-pfdhps triple mutations associated with anti-malarial drugs resistance in Plasmodium falciparum isolates seven years after the adoption of sulfadoxine-pyrimethamine in combination with artesunate as first-line treatment in Iran.
    Rouhani M; Zakeri S; Pirahmadi S; Raeisi A; Djadid ND
    Infect Genet Evol; 2015 Apr; 31():183-9. PubMed ID: 25653131
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular epidemiology and evolution of drug-resistant genes in the malaria parasite Plasmodium falciparum in southwestern Nigeria.
    Oboh MA; Singh US; Antony HA; Ndiaye D; Badiane AS; Ali NA; Bharti PK; Das A
    Infect Genet Evol; 2018 Dec; 66():222-228. PubMed ID: 30316883
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-level Plasmodium falciparum sulfadoxine-pyrimethamine resistance with the concomitant occurrence of septuple haplotype in Tanzania.
    Baraka V; Ishengoma DS; Fransis F; Minja DT; Madebe RA; Ngatunga D; Van Geertruyden JP
    Malar J; 2015 Nov; 14():439. PubMed ID: 26542942
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasmodium falciparum pfcrt and pfmdr1 polymorphisms are associated with the pfdhfr N108 pyrimethamine-resistance mutation in isolates from Ghana.
    Mockenhaupt FP; Eggelte TA; Till H; Bienzle U
    Trop Med Int Health; 2001 Oct; 6(10):749-55. PubMed ID: 11679121
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation of
    Sharma S; Bharti RS; Bhardwaj N; Anvikar AR; Valecha N; Mishra N
    Indian J Med Microbiol; 2017; 35(4):485-490. PubMed ID: 29405138
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High prevalence of asymptomatic malaria in a tribal population in eastern India.
    Ganguly S; Saha P; Guha SK; Biswas A; Das S; Kundu PK; Maji AK
    J Clin Microbiol; 2013 May; 51(5):1439-44. PubMed ID: 23426929
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug resistance profiling of asymptomatic and low-density Plasmodium falciparum malaria infections on Ngodhe island, Kenya, using custom dual-indexing next-generation sequencing.
    Osborne A; Phelan JE; Kaneko A; Kagaya W; Chan C; Ngara M; Kongere J; Kita K; Gitaka J; Campino S; Clark TG
    Sci Rep; 2023 Jul; 13(1):11416. PubMed ID: 37452073
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular monitoring of Plasmodium falciparum resistance to antimalarial drugs after adoption of sulfadoxine-pyrimethamine plus artesunate as the first line treatment in Iran.
    Afsharpad M; Zakeri S; Pirahmadi S; Djadid ND
    Acta Trop; 2012 Jan; 121(1):13-8. PubMed ID: 22001304
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sustained efficacy of artesunate-sulfadoxine-pyrimethamine against Plasmodium falciparum in Yemen and a renewed call for an adjunct single dose primaquine to clear gametocytes.
    Atroosh WM; Al-Mekhlafi HM; Snounou G; Al-Jasari A; Sady H; Nasr NA; Lau YL; Surin J
    Malar J; 2016 May; 15(1):295. PubMed ID: 27234587
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selection of antimalarial drug resistance after intermittent preventive treatment of infants and children (IPTi/c) in Senegal.
    Ndiaye M; Tine R; Faye B; Ndiaye JL; Diouf I; Lo AC; Sylla K; Dieng Y; Hallett R; Alifrangis M; Gaye O
    C R Biol; 2013; 336(5-6):295-300. PubMed ID: 23916206
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of drug resistance marker genes of
    Ozarkar A; Kanyal A; Dass S; Deshpande P; Deobagkar D; Karmodiya K
    J Biosci; 2021; 46():. PubMed ID: 34344849
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular surveillance of drug-resistance associated mutations of Plasmodium falciparum in south-west Tanzania.
    Schönfeld M; Barreto Miranda I; Schunk M; Maduhu I; Maboko L; Hoelscher M; Berens-Riha N; Kitua A; Löscher T
    Malar J; 2007 Jan; 6():2. PubMed ID: 17224049
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of molecular markers of sulfadoxine-pyrimethamine and artemisinin resistance in Plasmodium falciparum from Pakistan.
    Yaqoob A; Khattak AA; Nadeem MF; Fatima H; Mbambo G; Ouattara A; Adams M; Zeeshan N; Takala-Harrison S
    Malar J; 2018 Dec; 17(1):471. PubMed ID: 30558587
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of the Pfdhfr and Pfdhps mutations among asymptomatic pregnant women in Southeast Nigeria.
    Esu E; Tacoli C; Gai P; Berens-Riha N; Pritsch M; Loescher T; Meremikwu M
    Parasitol Res; 2018 Mar; 117(3):801-807. PubMed ID: 29332155
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Two decades of molecular surveillance in Senegal reveal rapid changes in known drug resistance mutations over time.
    Ndiaye YD; Wong W; Thwing J; Schaffner SF; Brenneman KV; Tine A; Diallo MA; Deme AB; Sy M; Bei AK; Thiaw AB; Daniels R; Ndiaye T; Gaye A; Ndiaye IM; Toure M; Gadiaga N; Sene A; Sow D; Garba MN; Yade MS; Dieye B; Diongue K; Zoumarou D; Ndiaye A; Gomis JF; Fall FB; Ndiop M; Diallo I; Sene D; Macinnis B; Seck MC; Ndiaye M; Ngom B; Diedhiou Y; Mbaye AM; Ndiaye L; Sy N; Badiane AS; Hartl DL; Wirth DF; Volkman SK; Ndiaye D
    Malar J; 2024 Jul; 23(1):205. PubMed ID: 38982475
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular markers associated with resistance to commonly used antimalarial drugs among Plasmodium falciparum isolates from a malaria-endemic area in Taiz governorate-Yemen during the transmission season.
    Alareqi LMQ; Mahdy MAK; Lau YL; Fong MY; Abdul-Ghani R; Mahmud R
    Acta Trop; 2016 Oct; 162():174-179. PubMed ID: 27343362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.